0001628280-22-023059.txt : 20220816
0001628280-22-023059.hdr.sgml : 20220816
20220816181339
ACCESSION NUMBER: 0001628280-22-023059
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220815
FILED AS OF DATE: 20220816
DATE AS OF CHANGE: 20220816
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DeRosa Anthony John
CENTRAL INDEX KEY: 0001868397
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39417
FILM NUMBER: 221171556
MAIL ADDRESS:
STREET 1: C/O EVOLV TECHNOLOGIES, INC.
STREET 2: 500 TOTTEN POND ROAD, 4TH FLOOR
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Evolv Technologies Holdings, Inc.
CENTRAL INDEX KEY: 0001805385
STANDARD INDUSTRIAL CLASSIFICATION: COMPUTER PERIPHERAL EQUIPMENT, NEC [3577]
IRS NUMBER: 844473840
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12141 WICKCHESTER LN., SUITE 325
CITY: HOUSTON
STATE: TX
ZIP: 77079
BUSINESS PHONE: 212-653-0153
MAIL ADDRESS:
STREET 1: 12141 WICKCHESTER LN., SUITE 325
CITY: HOUSTON
STATE: TX
ZIP: 77079
FORMER COMPANY:
FORMER CONFORMED NAME: NewHold Investment Corp.
DATE OF NAME CHANGE: 20200303
4
1
wf-form4_166068800415484.xml
FORM 4
X0306
4
2022-08-15
0
0001805385
Evolv Technologies Holdings, Inc.
EVLV
0001868397
DeRosa Anthony John
C/O EVOLV TECHNOLOGIES HOLDINGS, INC.
500 TOTTEN POND ROAD, 4TH FLOOR
WALTHAM
MA
02451
0
1
0
0
Chief Revenue Officer
Class A Common Stock
2022-08-15
4
M
0
10000
0.42
A
10000
D
Class A Common Stock
2022-08-15
4
S
0
10000
3.2758
D
0
D
Stock Option (Right to Buy)
0.42
2022-08-15
4
M
0
10000
0
D
2031-01-10
Class A Common Stock
10000.0
1069895
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on March 17, 2022.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.20 to $3.40. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option vests and becomes exercisable as to 25% of the shares on October 1, 2021 and in 36 equal monthly installments thereafter.
/s/ Eric Pyenson, Attorney-in-fact for Anthony John DeRosa
2022-08-16